Señales en vivo de QUIA.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:29):

Stats
Volumen de hoy	2.85M
Volumen promedio	1.66M
Capitalización de mercado	6.15M
EPS	SEK-1.220 ( 2022-12-31 )
Próxima fecha de ganancias	( SEK0 ) 2024-06-14
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-2.67
ATR14	SEK0.00200 (2.50%)

Volumen Correlación

Largo: -0.14 (neutral)

Corto: 0.26 (neutral)

Signal:(58.129) Neutral

QuiaPEG Pharmaceuticals Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

QuiaPEG Pharmaceuticals Correlación - Moneda/Commodity

-0.44
( neutral )

-0.32
( neutral )

0.00
( neutral )

0.09
( neutral )

QuiaPEG Pharmaceuticals Finanzas

Annual	2023
Ingresos:	SEK4.37M
Beneficio Bruto:	SEK2.29M (52.42 %)
EPS:	SEK-0.0335

FY	2023
Ingresos:	SEK4.37M
Beneficio Bruto:	SEK2.29M (52.42 %)
EPS:	SEK-0.0335

FY	2022
Ingresos:	SEK5.57M
Beneficio Bruto:	SEK8.91M (159.81 %)
EPS:	SEK-6.80

FY	2021
Ingresos:	SEK0.00
Beneficio Bruto:	SEK311 000 (0.00 %)
EPS:	SEK-0.320

Financial Reports:

No articles found.

QuiaPEG Pharmaceuticals

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.